Alpha gene number plays an important role in modulating the phenotype of thalassemia. It has been known that the coexistence of a-globin gene triplication (aaa) is an important modulator of the severity of b-thalassemia trait, exacerbating the phenotypic severity of b-thalassemia by causing more globin chain imbalance [1, 2] . Therefore characterization of a-globin gene mutations can be of great help in identification of hemoglobinopathies. Different frequencies of a-globin triplication have already been reported in many populations [3] [4] [5] [6] . However, there has been no epidemiological study of a-globin gene triplication in Chinese. Here, we report the prevalence of a-globin triplication in a southern China population with high prevalence of b-thalassemia.
During a one-month period of June 2014, 1169 sequential cord blood samples at birth were collected from the delivery unit, Guangzhou Women and Children Medical Center, Guangdong, China. The samples were frozen and stored at -20°C up to the time of molecular investigation. Genomic DNA was extracted from leukocytes using phenol-chloroform-based method. The multiplex Gap-PCR method described by Wang et junction, multiplex ligation-dependent probe amplification (MLPA) was used to confirm the presence of extra copies of a-globin gene. MLPA can also discriminate between heterozygote and homozygote triplication. For samples with either an aaa anti3.7 or aaa anti4.2 junction, the tworound nested PCR strategies were also used to detect the HKaa or anti-HKaa allele according to previous studies [8, 9] .
Among the 1169 cord blood samples of newborns with Chinese ethnicity, 11 were positive for aaa anti3.7 junction and 9 positive for aaa anti4.2 junction (Fig. 1 ). In the 9 samples positive for aaa anti4.2 , -a 3.7 junction was found in 5 cases which were confirmed to carry the HKaa allele. Among the 11 cases positive for aaa anti3.7 , no -a 4.2 junction was detected, thus excluding the presence of antiHKaa allele. All of the 11 samples with simple aaa anti3.7 triplication and 4 samples with simple aaa anti4.2 triplication were also confirmed to have an extra copy of a-globin gene by MLPA (Fig. 2) . Therefore the population-based prevalence of a-globin gene triplication was 0.9 % for aaa anti3.7 and 0.3 % for aaa anti4.2 triplication. The allelic frequencies of aaa anti3.7 and aaa anti4.2 triplications were 0.0045 and 0.0015, respectively.
Triplication is a relatively common numerical change of a-globin gene. The reported frequencies of aaa anti 3.7 triplication varied from 0.04 % in Sardinians, 0.36 % in American Blacks, 1 % in a multi ethnic population in The Netherland to 5 % in Greek Cypriots [3] [4] [5] [6] . There was no data available for the prevalence of aaa anti4.2 triplication, which might be due to its rare existence. In this study, we first reported the carrier frequencies of a-globin gene triplications in southern China. Corresponding to the more common of -a 3.7 than -a 4.2 deletion, the frequency (0.9 %) of aaa anti3.7 triplication was far higher than that (0.3 %) of aaa anti4.2 triplication. In total, we found a carrier frequency of 1.2 % in southern Chinese individuals for a-globin gene triplications. Since b-thalassemia is one of the most common monogenic disorders in southern China, it can be expected that the coexistence of triplicated a-globin gene and ß-thalassemia should be a cause of thalassemia intermedia in our locality [10] . Therefore the presence of triplicated a-globin genes should be considered in apparent ß-thalassemia carriers who were more anemic and symptomatic than expected. The information on the a-globin gene triplication is also of importance in terms of genetic counseling, especially in families with children affected by ß-thalassemia intermedia, while only one parent showed a picture of ß-thalassemia on hematological analysis. We also reported a carrier frequency (0.4 %) of the HKaa allele in our population. The HKaa is an a-globin gene cluster containing both -a 3.7 and aaa anti4.2 junctions [8] . This allele contains an intact a2 gene and a a1-a2 fusion gene (-a 3.7 ) with neither decreased nor enhanced aglobin gene dosage. We have confirmed that compound heterozygosity for HKaa and an in cis deletion of double a genes presents as a-thalassemia trait [11] . It can also be speculated that carriers of b-thalassemia trait are unlikely to suffer any more deteriorative effects when combined with the HKaa allele since its imbalanced a/b ratio is unchanged.
